AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors

Masahiro Nakagawa(Columbia University Irving Medical Center), Mineo Kurokawa(The University of Tokyo)
Blood
October 22, 2011
Cited by 60


Related Papers